EMA Authorised: Roclanda (Latanoprost;netarsudil mesilate) — Santen Oy

View source ↗

Summary

The European Medicines Agency has authorised Roclanda, a fixed-dose combination of latanoprost and netarsudil mesilate, for use in open-angle glaucoma and ocula…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glaucoma Open-angle
• Ocular Hypertension

Drugs mentioned

• Roclanda (latanoprost; netarsudil mesilate)

Snippet

Status: Authorised. Therapeutic area: Glaucoma, Open-Angle;Ocular Hypertension. MAH: Santen Oy. Decision date: 12/02/2026